FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh.

Authors

• A W Thomson
• P B Carroll
• J McCauley
• J Woo
• K Abu-Elmagd
• T E Starzl
• D H Van Thiel

Publication/Presentation Date

1-1-1993

Volume

14

Issue

4

First Page

323

Last Page

344

ISSN

0344-4325

Published In/Presented At

Thomson, A. W., Carroll, P. B., McCauley, J., Woo, J., Abu-Elmagd, K., Starzl, T. E., & Van Thiel, D. H. (1993). FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh. Springer seminars in immunopathology, 14(4), 323–344. https://doi.org/10.1007/BF00192307

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

7686690

Department(s)

Administration and Leadership

Document Type

Article